Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Issue of Equity

9 Mar 2012 16:16

RNS Number : 0964Z
First Derivatives PLC
09 March 2012
 

First Derivatives plc (the "Company")

(AIM:FDP.L, ESM:FDP:I)

 

Exercise of Options

 

The Board announces that, following the exercise of options by certain employees, 170,667 ordinary shares in the Company have been issued and allotted.

 

Accordingly, application has been made for the 170,667 new ordinary shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 15 March 2012.

 

The new ordinary shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 16,803,702 ordinary shares.

 

9 March 2012

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive

www.firstderivatives.com

Graham Ferguson, Chief Financial Officer

Charles Stanley Securities(Nominated Adviser)

+44 (0)20 7149 6000

Russell Cook

Carl Holmes

Goodbody Corporate Finance(ESM Adviser)

+353 1 667 0420

Linda Hickey

Finbarr Griffin

Walbrook PR

+44 (0)20 7933 8780

Bob Huxford

bob@walbrookpr.com

Fiona Henson

fiona@walbrookpr.com

Stakeholder Communications

+44 (0) 2890 339949

Carl Whyte

John Hart

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBKCDDABKDBNK
Date   Source Headline
18th Jun 20244:21 pmRNSNotice of AGM
28th May 20243:04 pmRNSHolding(s) in Company
21st May 20247:00 amRNSFull Year Results 2023/24
9th May 20249:11 amRNSHolding(s) in Company
8th May 20243:49 pmRNSHolding(s) in Company
2nd May 20247:00 amRNSHolding(s) in Company
1st May 20249:25 amRNSTotal Voting Rights
30th Apr 20243:39 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
23rd Apr 20247:00 amRNSNotice of Results
22nd Apr 20244:11 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSHolding(s) in Company
15th Apr 20246:14 pmRNSIssue of Equity
8th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:14 pmRNSHolding(s) in Company
2nd Apr 20243:43 pmRNSHolding(s) in Company
2nd Apr 20243:26 pmRNSHolding(s) in Company
2nd Apr 20248:39 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20243:24 pmRNSHolding(s) in Company
19th Mar 20244:35 pmRNSIssue of Equity
18th Mar 20244:22 pmRNSHolding(s) in Company
15th Mar 20246:23 pmRNSHolding(s) in Company
15th Mar 20245:27 pmRNSCorrection - Holding(s) in Company
15th Mar 20245:20 pmRNSHolding(s) in Company
15th Mar 20244:43 pmRNSHolding(s) in Company
13th Mar 20245:15 pmRNSHolding(s) in Company
13th Mar 20244:34 pmRNSHolding(s) in Company
13th Mar 202410:45 amRNSHolding(s) in Company
11th Mar 202412:15 pmRNSHolding(s) in Company
11th Mar 202411:47 amRNSDirector/PDMR Shareholding
7th Mar 202410:57 amRNSHolding(s) in Company
6th Mar 20244:50 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSHolding(s) in Company
1st Mar 20247:00 amRNSConclusion of Structure Review
1st Mar 20247:00 amRNSFY24 Trading Update
15th Jan 20245:43 pmRNSHolding(s) in Company
19th Dec 20235:27 pmRNSCorrection: Holding(s) in Company
18th Dec 20237:00 amRNSHolding(s) in Company
15th Dec 20237:00 amRNSDirectorate Change
29th Nov 20237:00 amRNSKX hosts Investor Event: Winning in the AI Era
28th Nov 20237:00 amRNSLaunch of KDB.AI Server
22nd Nov 20231:54 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Nov 20238:57 amRNSDirector/PDMR Shareholding
13th Nov 20233:04 pmRNSHolding(s) in Company
6th Nov 20237:00 amRNSNotice of KX Investor Event
24th Oct 20237:00 amRNSResults for the six months ended 31 August 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.